nodes	percent_of_prediction	percent_of_DWPC	metapath
Brinzolamide—Rhinorrhoea—Sorafenib—liver cancer	0.0166	0.0221	CcSEcCtD
Brinzolamide—Blood pressure increased—Sorafenib—liver cancer	0.0134	0.0179	CcSEcCtD
Brinzolamide—Pain in extremity—Sorafenib—liver cancer	0.00974	0.013	CcSEcCtD
Brinzolamide—Abdominal pain upper—Sorafenib—liver cancer	0.0089	0.0119	CcSEcCtD
Brinzolamide—Breast disorder—Sorafenib—liver cancer	0.0088	0.0117	CcSEcCtD
Brinzolamide—Nasopharyngitis—Sorafenib—liver cancer	0.00871	0.0116	CcSEcCtD
Brinzolamide—Lacrimation—Epirubicin—liver cancer	0.00843	0.0113	CcSEcCtD
Brinzolamide—Abdominal discomfort—Sorafenib—liver cancer	0.00807	0.0108	CcSEcCtD
Brinzolamide—Lacrimation—Doxorubicin—liver cancer	0.0078	0.0104	CcSEcCtD
Brinzolamide—Erectile dysfunction—Sorafenib—liver cancer	0.00775	0.0103	CcSEcCtD
Brinzolamide—Keratitis—Epirubicin—liver cancer	0.00765	0.0102	CcSEcCtD
Brinzolamide—Infestation—Sorafenib—liver cancer	0.00751	0.01	CcSEcCtD
Brinzolamide—Infestation NOS—Sorafenib—liver cancer	0.00751	0.01	CcSEcCtD
Brinzolamide—Hepatobiliary disease—Sorafenib—liver cancer	0.0071	0.00948	CcSEcCtD
Brinzolamide—Epistaxis—Sorafenib—liver cancer	0.00708	0.00945	CcSEcCtD
Brinzolamide—Keratitis—Doxorubicin—liver cancer	0.00707	0.00944	CcSEcCtD
Brinzolamide—Urinary tract disorder—Sorafenib—liver cancer	0.00665	0.00888	CcSEcCtD
Brinzolamide—Connective tissue disorder—Sorafenib—liver cancer	0.00662	0.00884	CcSEcCtD
Brinzolamide—Urethral disorder—Sorafenib—liver cancer	0.00661	0.00882	CcSEcCtD
Brinzolamide—Tinnitus—Sorafenib—liver cancer	0.00628	0.00839	CcSEcCtD
Brinzolamide—Cardiac disorder—Sorafenib—liver cancer	0.00625	0.00835	CcSEcCtD
Brinzolamide—Ageusia—Epirubicin—liver cancer	0.00612	0.00817	CcSEcCtD
Brinzolamide—Angiopathy—Sorafenib—liver cancer	0.00611	0.00816	CcSEcCtD
Brinzolamide—Immune system disorder—Sorafenib—liver cancer	0.00609	0.00812	CcSEcCtD
Brinzolamide—Mediastinal disorder—Sorafenib—liver cancer	0.00607	0.00811	CcSEcCtD
Brinzolamide—Arrhythmia—Sorafenib—liver cancer	0.00602	0.00804	CcSEcCtD
Brinzolamide—Alopecia—Sorafenib—liver cancer	0.00595	0.00795	CcSEcCtD
Brinzolamide—Mental disorder—Sorafenib—liver cancer	0.0059	0.00788	CcSEcCtD
Brinzolamide—Erythema—Sorafenib—liver cancer	0.00587	0.00783	CcSEcCtD
Brinzolamide—Malnutrition—Sorafenib—liver cancer	0.00587	0.00783	CcSEcCtD
Brinzolamide—Dysgeusia—Sorafenib—liver cancer	0.00574	0.00767	CcSEcCtD
Brinzolamide—Ageusia—Doxorubicin—liver cancer	0.00566	0.00756	CcSEcCtD
Brinzolamide—Muscle spasms—Sorafenib—liver cancer	0.00564	0.00753	CcSEcCtD
Brinzolamide—Lacrimation increased—Epirubicin—liver cancer	0.00538	0.00718	CcSEcCtD
Brinzolamide—Cough—Sorafenib—liver cancer	0.00512	0.00683	CcSEcCtD
Brinzolamide—Hypertension—Sorafenib—liver cancer	0.00506	0.00676	CcSEcCtD
Brinzolamide—Arthralgia—Sorafenib—liver cancer	0.00499	0.00667	CcSEcCtD
Brinzolamide—Myalgia—Sorafenib—liver cancer	0.00499	0.00667	CcSEcCtD
Brinzolamide—Lacrimation increased—Doxorubicin—liver cancer	0.00498	0.00665	CcSEcCtD
Brinzolamide—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.00496	0.00662	CcSEcCtD
Brinzolamide—Dry mouth—Sorafenib—liver cancer	0.00488	0.00652	CcSEcCtD
Brinzolamide—Infection—Sorafenib—liver cancer	0.00476	0.00635	CcSEcCtD
Brinzolamide—Nervous system disorder—Sorafenib—liver cancer	0.00469	0.00627	CcSEcCtD
Brinzolamide—Skin disorder—Sorafenib—liver cancer	0.00465	0.00621	CcSEcCtD
Brinzolamide—Dry eye—Epirubicin—liver cancer	0.00458	0.00611	CcSEcCtD
Brinzolamide—Oesophagitis—Epirubicin—liver cancer	0.00453	0.00605	CcSEcCtD
Brinzolamide—Rash maculo-papular—Epirubicin—liver cancer	0.00451	0.00602	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Sorafenib—liver cancer	0.00436	0.00582	CcSEcCtD
Brinzolamide—Hypertonia—Epirubicin—liver cancer	0.00435	0.0058	CcSEcCtD
Brinzolamide—Abnormal vision—Epirubicin—liver cancer	0.00433	0.00577	CcSEcCtD
Brinzolamide—Dyspnoea—Sorafenib—liver cancer	0.00427	0.0057	CcSEcCtD
Brinzolamide—Dry eye—Doxorubicin—liver cancer	0.00424	0.00566	CcSEcCtD
Brinzolamide—Dyspepsia—Sorafenib—liver cancer	0.00421	0.00563	CcSEcCtD
Brinzolamide—Oesophagitis—Doxorubicin—liver cancer	0.00419	0.0056	CcSEcCtD
Brinzolamide—Rash maculo-papular—Doxorubicin—liver cancer	0.00417	0.00557	CcSEcCtD
Brinzolamide—Decreased appetite—Sorafenib—liver cancer	0.00416	0.00556	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Sorafenib—liver cancer	0.00413	0.00552	CcSEcCtD
Brinzolamide—Fatigue—Sorafenib—liver cancer	0.00413	0.00551	CcSEcCtD
Brinzolamide—Pain—Sorafenib—liver cancer	0.00409	0.00546	CcSEcCtD
Brinzolamide—Hypertonia—Doxorubicin—liver cancer	0.00402	0.00537	CcSEcCtD
Brinzolamide—Abnormal vision—Doxorubicin—liver cancer	0.004	0.00534	CcSEcCtD
Brinzolamide—Eye pain—Epirubicin—liver cancer	0.00399	0.00532	CcSEcCtD
Brinzolamide—Urticaria—Sorafenib—liver cancer	0.0038	0.00508	CcSEcCtD
Brinzolamide—Eye pain—Doxorubicin—liver cancer	0.00369	0.00492	CcSEcCtD
Brinzolamide—Pain in extremity—Epirubicin—liver cancer	0.0036	0.00481	CcSEcCtD
Brinzolamide—Diplopia—Epirubicin—liver cancer	0.0036	0.00481	CcSEcCtD
Brinzolamide—Hypersensitivity—Sorafenib—liver cancer	0.00353	0.00471	CcSEcCtD
Brinzolamide—Asthenia—Sorafenib—liver cancer	0.00343	0.00458	CcSEcCtD
Brinzolamide—Pruritus—Sorafenib—liver cancer	0.00339	0.00452	CcSEcCtD
Brinzolamide—Diplopia—Doxorubicin—liver cancer	0.00333	0.00445	CcSEcCtD
Brinzolamide—Pain in extremity—Doxorubicin—liver cancer	0.00333	0.00445	CcSEcCtD
Brinzolamide—Liver function test abnormal—Epirubicin—liver cancer	0.00332	0.00444	CcSEcCtD
Brinzolamide—Abdominal pain upper—Epirubicin—liver cancer	0.00329	0.00439	CcSEcCtD
Brinzolamide—Diarrhoea—Sorafenib—liver cancer	0.00328	0.00437	CcSEcCtD
Brinzolamide—Breast disorder—Epirubicin—liver cancer	0.00325	0.00434	CcSEcCtD
Brinzolamide—Nasopharyngitis—Epirubicin—liver cancer	0.00322	0.0043	CcSEcCtD
Brinzolamide—Dizziness—Sorafenib—liver cancer	0.00317	0.00423	CcSEcCtD
Brinzolamide—Asthma—Epirubicin—liver cancer	0.00311	0.00415	CcSEcCtD
Brinzolamide—Liver function test abnormal—Doxorubicin—liver cancer	0.00308	0.0041	CcSEcCtD
Brinzolamide—Vomiting—Sorafenib—liver cancer	0.00304	0.00406	CcSEcCtD
Brinzolamide—Abdominal pain upper—Doxorubicin—liver cancer	0.00304	0.00406	CcSEcCtD
Brinzolamide—Angina pectoris—Epirubicin—liver cancer	0.00303	0.00405	CcSEcCtD
Brinzolamide—Rash—Sorafenib—liver cancer	0.00302	0.00403	CcSEcCtD
Brinzolamide—Dermatitis—Sorafenib—liver cancer	0.00302	0.00403	CcSEcCtD
Brinzolamide—Breast disorder—Doxorubicin—liver cancer	0.00301	0.00402	CcSEcCtD
Brinzolamide—Headache—Sorafenib—liver cancer	0.003	0.004	CcSEcCtD
Brinzolamide—Bronchitis—Epirubicin—liver cancer	0.00299	0.00399	CcSEcCtD
Brinzolamide—Nasopharyngitis—Doxorubicin—liver cancer	0.00298	0.00398	CcSEcCtD
Brinzolamide—Asthma—Doxorubicin—liver cancer	0.00288	0.00384	CcSEcCtD
Brinzolamide—Pollakiuria—Epirubicin—liver cancer	0.00287	0.00384	CcSEcCtD
Brinzolamide—Nausea—Sorafenib—liver cancer	0.00284	0.0038	CcSEcCtD
Brinzolamide—Angina pectoris—Doxorubicin—liver cancer	0.0028	0.00374	CcSEcCtD
Brinzolamide—Infestation NOS—Epirubicin—liver cancer	0.00277	0.0037	CcSEcCtD
Brinzolamide—Infestation—Epirubicin—liver cancer	0.00277	0.0037	CcSEcCtD
Brinzolamide—Bronchitis—Doxorubicin—liver cancer	0.00277	0.0037	CcSEcCtD
Brinzolamide—Conjunctivitis—Epirubicin—liver cancer	0.0027	0.0036	CcSEcCtD
Brinzolamide—Pollakiuria—Doxorubicin—liver cancer	0.00266	0.00355	CcSEcCtD
Brinzolamide—Hepatobiliary disease—Epirubicin—liver cancer	0.00262	0.0035	CcSEcCtD
Brinzolamide—Epistaxis—Epirubicin—liver cancer	0.00262	0.00349	CcSEcCtD
Brinzolamide—Sinusitis—Epirubicin—liver cancer	0.0026	0.00347	CcSEcCtD
Brinzolamide—Infestation NOS—Doxorubicin—liver cancer	0.00257	0.00343	CcSEcCtD
Brinzolamide—Infestation—Doxorubicin—liver cancer	0.00257	0.00343	CcSEcCtD
Brinzolamide—Bradycardia—Epirubicin—liver cancer	0.00254	0.00338	CcSEcCtD
Brinzolamide—Rhinitis—Epirubicin—liver cancer	0.0025	0.00333	CcSEcCtD
Brinzolamide—Conjunctivitis—Doxorubicin—liver cancer	0.0025	0.00333	CcSEcCtD
Brinzolamide—Hypoaesthesia—Epirubicin—liver cancer	0.00248	0.00331	CcSEcCtD
Brinzolamide—Pharyngitis—Epirubicin—liver cancer	0.00247	0.0033	CcSEcCtD
Brinzolamide—Urinary tract disorder—Epirubicin—liver cancer	0.00246	0.00328	CcSEcCtD
Brinzolamide—Oedema peripheral—Epirubicin—liver cancer	0.00245	0.00327	CcSEcCtD
Brinzolamide—Connective tissue disorder—Epirubicin—liver cancer	0.00245	0.00327	CcSEcCtD
Brinzolamide—Urethral disorder—Epirubicin—liver cancer	0.00244	0.00326	CcSEcCtD
Brinzolamide—Hepatobiliary disease—Doxorubicin—liver cancer	0.00243	0.00324	CcSEcCtD
Brinzolamide—Epistaxis—Doxorubicin—liver cancer	0.00242	0.00323	CcSEcCtD
Brinzolamide—Sinusitis—Doxorubicin—liver cancer	0.00241	0.00321	CcSEcCtD
Brinzolamide—Visual impairment—Epirubicin—liver cancer	0.0024	0.0032	CcSEcCtD
Brinzolamide—Bradycardia—Doxorubicin—liver cancer	0.00235	0.00313	CcSEcCtD
Brinzolamide—Eye disorder—Epirubicin—liver cancer	0.00233	0.00311	CcSEcCtD
Brinzolamide—Tinnitus—Epirubicin—liver cancer	0.00232	0.0031	CcSEcCtD
Brinzolamide—Cardiac disorder—Epirubicin—liver cancer	0.00231	0.00309	CcSEcCtD
Brinzolamide—Rhinitis—Doxorubicin—liver cancer	0.00231	0.00308	CcSEcCtD
Brinzolamide—Hypoaesthesia—Doxorubicin—liver cancer	0.00229	0.00306	CcSEcCtD
Brinzolamide—Pharyngitis—Doxorubicin—liver cancer	0.00229	0.00305	CcSEcCtD
Brinzolamide—Urinary tract disorder—Doxorubicin—liver cancer	0.00228	0.00304	CcSEcCtD
Brinzolamide—Oedema peripheral—Doxorubicin—liver cancer	0.00227	0.00303	CcSEcCtD
Brinzolamide—Connective tissue disorder—Doxorubicin—liver cancer	0.00226	0.00302	CcSEcCtD
Brinzolamide—Angiopathy—Epirubicin—liver cancer	0.00226	0.00302	CcSEcCtD
Brinzolamide—Urethral disorder—Doxorubicin—liver cancer	0.00226	0.00302	CcSEcCtD
Brinzolamide—Immune system disorder—Epirubicin—liver cancer	0.00225	0.003	CcSEcCtD
Brinzolamide—Mediastinal disorder—Epirubicin—liver cancer	0.00224	0.003	CcSEcCtD
Brinzolamide—Arrhythmia—Epirubicin—liver cancer	0.00222	0.00297	CcSEcCtD
Brinzolamide—Visual impairment—Doxorubicin—liver cancer	0.00222	0.00296	CcSEcCtD
Brinzolamide—Alopecia—Epirubicin—liver cancer	0.0022	0.00294	CcSEcCtD
Brinzolamide—Mental disorder—Epirubicin—liver cancer	0.00218	0.00291	CcSEcCtD
Brinzolamide—Malnutrition—Epirubicin—liver cancer	0.00217	0.00289	CcSEcCtD
Brinzolamide—Erythema—Epirubicin—liver cancer	0.00217	0.00289	CcSEcCtD
Brinzolamide—Eye disorder—Doxorubicin—liver cancer	0.00215	0.00287	CcSEcCtD
Brinzolamide—Tinnitus—Doxorubicin—liver cancer	0.00215	0.00287	CcSEcCtD
Brinzolamide—Cardiac disorder—Doxorubicin—liver cancer	0.00214	0.00285	CcSEcCtD
Brinzolamide—Flatulence—Epirubicin—liver cancer	0.00214	0.00285	CcSEcCtD
Brinzolamide—Tension—Epirubicin—liver cancer	0.00213	0.00284	CcSEcCtD
Brinzolamide—Dysgeusia—Epirubicin—liver cancer	0.00212	0.00283	CcSEcCtD
Brinzolamide—Nervousness—Epirubicin—liver cancer	0.00211	0.00281	CcSEcCtD
Brinzolamide—Back pain—Epirubicin—liver cancer	0.0021	0.0028	CcSEcCtD
Brinzolamide—Angiopathy—Doxorubicin—liver cancer	0.00209	0.00279	CcSEcCtD
Brinzolamide—Muscle spasms—Epirubicin—liver cancer	0.00208	0.00278	CcSEcCtD
Brinzolamide—Immune system disorder—Doxorubicin—liver cancer	0.00208	0.00278	CcSEcCtD
Brinzolamide—Mediastinal disorder—Doxorubicin—liver cancer	0.00208	0.00277	CcSEcCtD
Brinzolamide—Arrhythmia—Doxorubicin—liver cancer	0.00206	0.00275	CcSEcCtD
Brinzolamide—Vision blurred—Epirubicin—liver cancer	0.00204	0.00273	CcSEcCtD
Brinzolamide—Alopecia—Doxorubicin—liver cancer	0.00204	0.00272	CcSEcCtD
Brinzolamide—Mental disorder—Doxorubicin—liver cancer	0.00202	0.00269	CcSEcCtD
Brinzolamide—Ill-defined disorder—Epirubicin—liver cancer	0.00201	0.00268	CcSEcCtD
Brinzolamide—Erythema—Doxorubicin—liver cancer	0.00201	0.00268	CcSEcCtD
Brinzolamide—Malnutrition—Doxorubicin—liver cancer	0.00201	0.00268	CcSEcCtD
Brinzolamide—Agitation—Epirubicin—liver cancer	0.00199	0.00266	CcSEcCtD
Brinzolamide—Flatulence—Doxorubicin—liver cancer	0.00198	0.00264	CcSEcCtD
Brinzolamide—Tension—Doxorubicin—liver cancer	0.00197	0.00263	CcSEcCtD
Brinzolamide—Dysgeusia—Doxorubicin—liver cancer	0.00196	0.00262	CcSEcCtD
Brinzolamide—Malaise—Epirubicin—liver cancer	0.00195	0.00261	CcSEcCtD
Brinzolamide—Nervousness—Doxorubicin—liver cancer	0.00195	0.0026	CcSEcCtD
Brinzolamide—Vertigo—Epirubicin—liver cancer	0.00195	0.0026	CcSEcCtD
Brinzolamide—Back pain—Doxorubicin—liver cancer	0.00194	0.00259	CcSEcCtD
Brinzolamide—Muscle spasms—Doxorubicin—liver cancer	0.00193	0.00257	CcSEcCtD
Brinzolamide—Palpitations—Epirubicin—liver cancer	0.00192	0.00256	CcSEcCtD
Brinzolamide—Cough—Epirubicin—liver cancer	0.00189	0.00253	CcSEcCtD
Brinzolamide—Vision blurred—Doxorubicin—liver cancer	0.00189	0.00252	CcSEcCtD
Brinzolamide—Hypertension—Epirubicin—liver cancer	0.00187	0.0025	CcSEcCtD
Brinzolamide—Ill-defined disorder—Doxorubicin—liver cancer	0.00186	0.00248	CcSEcCtD
Brinzolamide—Myalgia—Epirubicin—liver cancer	0.00185	0.00246	CcSEcCtD
Brinzolamide—Arthralgia—Epirubicin—liver cancer	0.00185	0.00246	CcSEcCtD
Brinzolamide—Chest pain—Epirubicin—liver cancer	0.00185	0.00246	CcSEcCtD
Brinzolamide—Agitation—Doxorubicin—liver cancer	0.00184	0.00246	CcSEcCtD
Brinzolamide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.00183	0.00245	CcSEcCtD
Brinzolamide—Discomfort—Epirubicin—liver cancer	0.00182	0.00243	CcSEcCtD
Brinzolamide—Malaise—Doxorubicin—liver cancer	0.00181	0.00241	CcSEcCtD
Brinzolamide—Dry mouth—Epirubicin—liver cancer	0.00181	0.00241	CcSEcCtD
Brinzolamide—Vertigo—Doxorubicin—liver cancer	0.0018	0.00241	CcSEcCtD
Brinzolamide—Palpitations—Doxorubicin—liver cancer	0.00177	0.00237	CcSEcCtD
Brinzolamide—Infection—Epirubicin—liver cancer	0.00176	0.00235	CcSEcCtD
Brinzolamide—Cough—Doxorubicin—liver cancer	0.00175	0.00234	CcSEcCtD
Brinzolamide—Nervous system disorder—Epirubicin—liver cancer	0.00174	0.00232	CcSEcCtD
Brinzolamide—Hypertension—Doxorubicin—liver cancer	0.00173	0.00231	CcSEcCtD
Brinzolamide—Tachycardia—Epirubicin—liver cancer	0.00173	0.0023	CcSEcCtD
Brinzolamide—Skin disorder—Epirubicin—liver cancer	0.00172	0.00229	CcSEcCtD
Brinzolamide—Myalgia—Doxorubicin—liver cancer	0.00171	0.00228	CcSEcCtD
Brinzolamide—Chest pain—Doxorubicin—liver cancer	0.00171	0.00228	CcSEcCtD
Brinzolamide—Arthralgia—Doxorubicin—liver cancer	0.00171	0.00228	CcSEcCtD
Brinzolamide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.0017	0.00226	CcSEcCtD
Brinzolamide—Discomfort—Doxorubicin—liver cancer	0.00169	0.00225	CcSEcCtD
Brinzolamide—Dry mouth—Doxorubicin—liver cancer	0.00167	0.00223	CcSEcCtD
Brinzolamide—Hypotension—Epirubicin—liver cancer	0.00165	0.00221	CcSEcCtD
Brinzolamide—Infection—Doxorubicin—liver cancer	0.00163	0.00217	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Epirubicin—liver cancer	0.00161	0.00215	CcSEcCtD
Brinzolamide—Nervous system disorder—Doxorubicin—liver cancer	0.00161	0.00214	CcSEcCtD
Brinzolamide—Insomnia—Epirubicin—liver cancer	0.0016	0.00214	CcSEcCtD
Brinzolamide—Tachycardia—Doxorubicin—liver cancer	0.0016	0.00213	CcSEcCtD
Brinzolamide—Skin disorder—Doxorubicin—liver cancer	0.00159	0.00212	CcSEcCtD
Brinzolamide—Paraesthesia—Epirubicin—liver cancer	0.00159	0.00212	CcSEcCtD
Brinzolamide—Dyspnoea—Epirubicin—liver cancer	0.00158	0.00211	CcSEcCtD
Brinzolamide—Somnolence—Epirubicin—liver cancer	0.00157	0.0021	CcSEcCtD
Brinzolamide—Dyspepsia—Epirubicin—liver cancer	0.00156	0.00208	CcSEcCtD
Brinzolamide—Decreased appetite—Epirubicin—liver cancer	0.00154	0.00205	CcSEcCtD
Brinzolamide—Hypotension—Doxorubicin—liver cancer	0.00153	0.00204	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Epirubicin—liver cancer	0.00153	0.00204	CcSEcCtD
Brinzolamide—Fatigue—Epirubicin—liver cancer	0.00153	0.00204	CcSEcCtD
Brinzolamide—Pain—Epirubicin—liver cancer	0.00151	0.00202	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.00149	0.00199	CcSEcCtD
Brinzolamide—Insomnia—Doxorubicin—liver cancer	0.00148	0.00198	CcSEcCtD
Brinzolamide—Paraesthesia—Doxorubicin—liver cancer	0.00147	0.00196	CcSEcCtD
Brinzolamide—Dyspnoea—Doxorubicin—liver cancer	0.00146	0.00195	CcSEcCtD
Brinzolamide—Feeling abnormal—Epirubicin—liver cancer	0.00146	0.00195	CcSEcCtD
Brinzolamide—Somnolence—Doxorubicin—liver cancer	0.00146	0.00194	CcSEcCtD
Brinzolamide—Dyspepsia—Doxorubicin—liver cancer	0.00144	0.00192	CcSEcCtD
Brinzolamide—Decreased appetite—Doxorubicin—liver cancer	0.00142	0.0019	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Doxorubicin—liver cancer	0.00141	0.00189	CcSEcCtD
Brinzolamide—Fatigue—Doxorubicin—liver cancer	0.00141	0.00188	CcSEcCtD
Brinzolamide—Urticaria—Epirubicin—liver cancer	0.00141	0.00188	CcSEcCtD
Brinzolamide—Pain—Doxorubicin—liver cancer	0.0014	0.00187	CcSEcCtD
Brinzolamide—Feeling abnormal—Doxorubicin—liver cancer	0.00135	0.0018	CcSEcCtD
Brinzolamide—Hypersensitivity—Epirubicin—liver cancer	0.0013	0.00174	CcSEcCtD
Brinzolamide—Urticaria—Doxorubicin—liver cancer	0.0013	0.00174	CcSEcCtD
Brinzolamide—Asthenia—Epirubicin—liver cancer	0.00127	0.00169	CcSEcCtD
Brinzolamide—Pruritus—Epirubicin—liver cancer	0.00125	0.00167	CcSEcCtD
Brinzolamide—Diarrhoea—Epirubicin—liver cancer	0.00121	0.00162	CcSEcCtD
Brinzolamide—Hypersensitivity—Doxorubicin—liver cancer	0.00121	0.00161	CcSEcCtD
Brinzolamide—Asthenia—Doxorubicin—liver cancer	0.00117	0.00157	CcSEcCtD
Brinzolamide—Dizziness—Epirubicin—liver cancer	0.00117	0.00156	CcSEcCtD
Brinzolamide—Pruritus—Doxorubicin—liver cancer	0.00116	0.00155	CcSEcCtD
Brinzolamide—Vomiting—Epirubicin—liver cancer	0.00112	0.0015	CcSEcCtD
Brinzolamide—Diarrhoea—Doxorubicin—liver cancer	0.00112	0.0015	CcSEcCtD
Brinzolamide—Rash—Epirubicin—liver cancer	0.00112	0.00149	CcSEcCtD
Brinzolamide—Dermatitis—Epirubicin—liver cancer	0.00111	0.00149	CcSEcCtD
Brinzolamide—Headache—Epirubicin—liver cancer	0.00111	0.00148	CcSEcCtD
Brinzolamide—Dizziness—Doxorubicin—liver cancer	0.00108	0.00145	CcSEcCtD
Brinzolamide—Nausea—Epirubicin—liver cancer	0.00105	0.0014	CcSEcCtD
Brinzolamide—Vomiting—Doxorubicin—liver cancer	0.00104	0.00139	CcSEcCtD
Brinzolamide—Rash—Doxorubicin—liver cancer	0.00103	0.00138	CcSEcCtD
Brinzolamide—Dermatitis—Doxorubicin—liver cancer	0.00103	0.00138	CcSEcCtD
Brinzolamide—Headache—Doxorubicin—liver cancer	0.00103	0.00137	CcSEcCtD
Brinzolamide—Nausea—Doxorubicin—liver cancer	0.000972	0.0013	CcSEcCtD
Brinzolamide—CA6—Metabolism—CYCS—liver cancer	0.000398	0.00159	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—CYP2E1—liver cancer	0.000397	0.00158	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—CYP2E1—liver cancer	0.000397	0.00158	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—ALDOB—liver cancer	0.000396	0.00158	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—CRABP1—liver cancer	0.000394	0.00157	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—GSTA4—liver cancer	0.000391	0.00156	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—GOT2—liver cancer	0.000391	0.00156	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—GGT1—liver cancer	0.00039	0.00156	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—GOT1—liver cancer	0.00039	0.00156	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—GGT1—liver cancer	0.00039	0.00156	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—GOT1—liver cancer	0.00039	0.00156	CbGpPWpGaD
Brinzolamide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—liver cancer	0.000389	0.00155	CbGpPWpGaD
Brinzolamide—CYP3A4—Biological oxidations—GSTA4—liver cancer	0.000385	0.00153	CbGpPWpGaD
Brinzolamide—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—liver cancer	0.000384	0.00153	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—GSTA2—liver cancer	0.000381	0.00152	CbGpPWpGaD
Brinzolamide—CYP3A4—Metapathway biotransformation—GSTA4—liver cancer	0.00038	0.00151	CbGpPWpGaD
Brinzolamide—CA9—Cellular responses to stress—JUN—liver cancer	0.000379	0.00151	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—CRABP1—liver cancer	0.000378	0.00151	CbGpPWpGaD
Brinzolamide—CYP3A4—Biological oxidations—GSTA2—liver cancer	0.000375	0.0015	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—CYCS—liver cancer	0.000371	0.00148	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—CYCS—liver cancer	0.000371	0.00148	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—CYP2E1—liver cancer	0.000368	0.00147	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—GSTA1—liver cancer	0.000368	0.00147	CbGpPWpGaD
Brinzolamide—CA9—Cellular responses to stress—CDKN1A—liver cancer	0.000367	0.00146	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—GGT1—liver cancer	0.000364	0.00145	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—GOT1—liver cancer	0.000364	0.00145	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—GGT1—liver cancer	0.000364	0.00145	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—GOT1—liver cancer	0.000364	0.00145	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—NAT2—liver cancer	0.000363	0.00145	CbGpPWpGaD
Brinzolamide—CYP3A4—Biological oxidations—GSTA1—liver cancer	0.000362	0.00144	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—GSTP1—liver cancer	0.00036	0.00143	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—HPGDS—liver cancer	0.00036	0.00143	CbGpPWpGaD
Brinzolamide—CA9—Cellular responses to stress—MAPK8—liver cancer	0.000358	0.00143	CbGpPWpGaD
Brinzolamide—CYP3A4—Biological oxidations—NAT2—liver cancer	0.000358	0.00143	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—HMOX1—liver cancer	0.000355	0.00141	CbGpPWpGaD
Brinzolamide—CYP3A4—Metapathway biotransformation—NAT2—liver cancer	0.000353	0.00141	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—GSTP1—liver cancer	0.00035	0.0014	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—GSTP1—liver cancer	0.00035	0.0014	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—ALDOB—liver cancer	0.000348	0.00139	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—HMOX1—liver cancer	0.000346	0.00138	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—HMOX1—liver cancer	0.000346	0.00138	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—HPGDS—liver cancer	0.000345	0.00137	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—CYCS—liver cancer	0.000344	0.00137	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—GGT1—liver cancer	0.000337	0.00135	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—GOT1—liver cancer	0.000337	0.00135	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—CRABP1—liver cancer	0.000332	0.00133	CbGpPWpGaD
Brinzolamide—CA9—Cellular responses to stress—VEGFA—liver cancer	0.000331	0.00132	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—GSTM1—liver cancer	0.00033	0.00132	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—HPGDS—liver cancer	0.00033	0.00132	CbGpPWpGaD
Brinzolamide—CA9—Cellular responses to stress—STAT3—liver cancer	0.000328	0.00131	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—GSTP1—liver cancer	0.000327	0.0013	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—GSTP1—liver cancer	0.000327	0.0013	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—HMOX1—liver cancer	0.000323	0.00129	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—HMOX1—liver cancer	0.000323	0.00129	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—GSTM1—liver cancer	0.000322	0.00128	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—GSTM1—liver cancer	0.000322	0.00128	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—PSMA4—liver cancer	0.00032	0.00128	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—PSMD10—liver cancer	0.00032	0.00128	CbGpPWpGaD
Brinzolamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	0.000315	0.00126	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—CYP1A1—liver cancer	0.000313	0.00125	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—GOT2—liver cancer	0.000312	0.00124	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—PSMA4—liver cancer	0.000307	0.00122	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—PSMD10—liver cancer	0.000307	0.00122	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—CYP1A1—liver cancer	0.000305	0.00122	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—CYP1A1—liver cancer	0.000305	0.00122	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—GSTP1—liver cancer	0.000303	0.00121	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—GSTM1—liver cancer	0.000301	0.0012	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—GSTM1—liver cancer	0.000301	0.0012	CbGpPWpGaD
Brinzolamide—CYP3A4—Metapathway biotransformation—GPX3—liver cancer	0.0003	0.0012	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—HMOX1—liver cancer	0.000299	0.00119	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—GOT2—liver cancer	0.000299	0.00119	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—PSMA4—liver cancer	0.000295	0.00117	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—PSMD10—liver cancer	0.000295	0.00117	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—CYP2E1—liver cancer	0.000293	0.00117	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—MTHFR—liver cancer	0.000292	0.00116	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—HPGDS—liver cancer	0.000291	0.00116	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—PPARA—liver cancer	0.000287	0.00114	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—GOT2—liver cancer	0.000287	0.00114	CbGpPWpGaD
Brinzolamide—CYP3A4—Biological oxidations—HPGDS—liver cancer	0.000286	0.00114	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—CYP1A1—liver cancer	0.000285	0.00114	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—CYP1A1—liver cancer	0.000285	0.00114	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—MTHFR—liver cancer	0.000285	0.00113	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—MTHFR—liver cancer	0.000285	0.00113	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—CYP2E1—liver cancer	0.000281	0.00112	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—PPARA—liver cancer	0.000279	0.00111	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—PPARA—liver cancer	0.000279	0.00111	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—GSTM1—liver cancer	0.000279	0.00111	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—CYCS—liver cancer	0.000274	0.00109	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—CYP2E1—liver cancer	0.000269	0.00107	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—GGT1—liver cancer	0.000269	0.00107	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—GOT1—liver cancer	0.000269	0.00107	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—MTHFR—liver cancer	0.000266	0.00106	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—MTHFR—liver cancer	0.000266	0.00106	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—CYP1A1—liver cancer	0.000264	0.00105	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—CYCS—liver cancer	0.000263	0.00105	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—PPARA—liver cancer	0.000261	0.00104	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—PPARA—liver cancer	0.000261	0.00104	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—PSMD10—liver cancer	0.000259	0.00103	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—PSMA4—liver cancer	0.000259	0.00103	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—GGT1—liver cancer	0.000258	0.00103	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—GOT1—liver cancer	0.000258	0.00103	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—CYCS—liver cancer	0.000252	0.001	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—GOT2—liver cancer	0.000252	0.001	CbGpPWpGaD
Brinzolamide—CA9—Cellular responses to stress—TP53—liver cancer	0.00025	0.000997	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—GGT1—liver cancer	0.000247	0.000986	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—GOT1—liver cancer	0.000247	0.000986	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—MTHFR—liver cancer	0.000246	0.000981	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—PIK3CG—liver cancer	0.000245	0.000978	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—GSTP1—liver cancer	0.000242	0.000964	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—PPARA—liver cancer	0.000242	0.000963	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—PIK3CG—liver cancer	0.000239	0.000953	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—PIK3CG—liver cancer	0.000239	0.000953	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—HMOX1—liver cancer	0.000238	0.00095	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—PPARG—liver cancer	0.000237	0.000944	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—CYP2E1—liver cancer	0.000237	0.000944	CbGpPWpGaD
Brinzolamide—CYP3A4—Biological oxidations—CYP2E1—liver cancer	0.000233	0.000929	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—GSTP1—liver cancer	0.000232	0.000924	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—PPARG—liver cancer	0.000231	0.00092	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—PPARG—liver cancer	0.000231	0.00092	CbGpPWpGaD
Brinzolamide—CYP3A4—Metapathway biotransformation—CYP2E1—liver cancer	0.00023	0.000917	CbGpPWpGaD
Brinzolamide—CA9—Cellular responses to stress—IL6—liver cancer	0.000229	0.000912	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—HMOX1—liver cancer	0.000229	0.000911	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—PIK3CG—liver cancer	0.000223	0.00089	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—PIK3CG—liver cancer	0.000223	0.00089	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—GSTP1—liver cancer	0.000222	0.000886	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—GSTM1—liver cancer	0.000222	0.000886	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—CYCS—liver cancer	0.000222	0.000883	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—HMOX1—liver cancer	0.000219	0.000874	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—GGT1—liver cancer	0.000217	0.000867	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—GOT1—liver cancer	0.000217	0.000867	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—PIK3CD—liver cancer	0.000216	0.00086	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—PPARG—liver cancer	0.000215	0.000859	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—PPARG—liver cancer	0.000215	0.000859	CbGpPWpGaD
Brinzolamide—CYP3A4—Biological oxidations—GGT1—liver cancer	0.000214	0.000853	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—ALB—liver cancer	0.000213	0.000849	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—GSTM1—liver cancer	0.000213	0.000849	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—CYP1A1—liver cancer	0.000211	0.000839	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—PIK3CD—liver cancer	0.00021	0.000838	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—PIK3CD—liver cancer	0.00021	0.000838	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—ALB—liver cancer	0.000208	0.000827	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—ALB—liver cancer	0.000208	0.000827	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—PIK3CG—liver cancer	0.000207	0.000825	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—GSTM1—liver cancer	0.000204	0.000814	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—CYP1A1—liver cancer	0.000202	0.000805	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—PPARG—liver cancer	0.0002	0.000796	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—MTHFR—liver cancer	0.000196	0.000783	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—PIK3CD—liver cancer	0.000196	0.000782	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—PIK3CD—liver cancer	0.000196	0.000782	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—GSTP1—liver cancer	0.000195	0.000779	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—ALB—liver cancer	0.000194	0.000772	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—ALB—liver cancer	0.000194	0.000772	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—CYP1A1—liver cancer	0.000194	0.000772	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—HMOX1—liver cancer	0.000193	0.000768	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—PPARA—liver cancer	0.000193	0.000768	CbGpPWpGaD
Brinzolamide—CYP3A4—Biological oxidations—GSTP1—liver cancer	0.000192	0.000767	CbGpPWpGaD
Brinzolamide—CYP3A4—Metapathway biotransformation—GSTP1—liver cancer	0.00019	0.000756	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—MTHFR—liver cancer	0.000188	0.00075	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—PIK3CB—liver cancer	0.000188	0.00075	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—PPARA—liver cancer	0.000185	0.000736	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—PIK3CB—liver cancer	0.000183	0.000731	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—PIK3CB—liver cancer	0.000183	0.000731	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—PIK3CD—liver cancer	0.000182	0.000725	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—MTHFR—liver cancer	0.00018	0.000719	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—GSTM1—liver cancer	0.000179	0.000716	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—ALB—liver cancer	0.000179	0.000716	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—PPARA—liver cancer	0.000177	0.000706	CbGpPWpGaD
Brinzolamide—CYP3A4—Biological oxidations—GSTM1—liver cancer	0.000177	0.000704	CbGpPWpGaD
Brinzolamide—CYP3A4—Metapathway biotransformation—GSTM1—liver cancer	0.000174	0.000695	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—PIK3CB—liver cancer	0.000171	0.000682	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—PIK3CB—liver cancer	0.000171	0.000682	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—CYP1A1—liver cancer	0.00017	0.000678	CbGpPWpGaD
Brinzolamide—CYP3A4—Biological oxidations—CYP1A1—liver cancer	0.000167	0.000668	CbGpPWpGaD
Brinzolamide—CYP3A4—Metapathway biotransformation—CYP1A1—liver cancer	0.000165	0.000659	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—PIK3CG—liver cancer	0.000165	0.000658	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—PPARG—liver cancer	0.000159	0.000635	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—MTHFR—liver cancer	0.000159	0.000632	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—PIK3CB—liver cancer	0.000158	0.000632	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—PIK3CG—liver cancer	0.000158	0.00063	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—PPARA—liver cancer	0.000156	0.00062	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—PPARG—liver cancer	0.000153	0.000608	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—PIK3CG—liver cancer	0.000152	0.000604	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—PPARG—liver cancer	0.000146	0.000583	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—PIK3CD—liver cancer	0.000145	0.000578	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—ALB—liver cancer	0.000143	0.000571	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—PIK3CD—liver cancer	0.000139	0.000554	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—ALB—liver cancer	0.000137	0.000547	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—PIK3CG—liver cancer	0.000133	0.000531	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—PIK3CD—liver cancer	0.000133	0.000531	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—ALB—liver cancer	0.000132	0.000525	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—PPARG—liver cancer	0.000129	0.000513	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—PIK3CB—liver cancer	0.000126	0.000504	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—UGDH—liver cancer	0.000125	0.000499	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—PIK3CB—liver cancer	0.000121	0.000483	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—EPT1—liver cancer	0.000118	0.00047	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—PIK3CD—liver cancer	0.000117	0.000467	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—PIK3CB—liver cancer	0.000116	0.000463	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—ALB—liver cancer	0.000116	0.000461	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—PIK3CA—liver cancer	0.000115	0.000457	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—PIK3CA—liver cancer	0.000112	0.000445	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—PIK3CA—liver cancer	0.000112	0.000445	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—TAT—liver cancer	0.000112	0.000445	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—PIK3CA—liver cancer	0.000104	0.000416	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—PIK3CA—liver cancer	0.000104	0.000416	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—PIK3CB—liver cancer	0.000102	0.000407	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—PIK3CA—liver cancer	9.66e-05	0.000385	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—AKT1—liver cancer	9.36e-05	0.000373	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—AKT1—liver cancer	9.13e-05	0.000364	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—AKT1—liver cancer	9.13e-05	0.000364	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—AKT1—liver cancer	8.52e-05	0.00034	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—AKT1—liver cancer	8.52e-05	0.00034	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—AKT1—liver cancer	7.89e-05	0.000315	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—PIK3CA—liver cancer	7.7e-05	0.000307	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—CPT1B—liver cancer	7.59e-05	0.000303	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—GLUL—liver cancer	7.59e-05	0.000303	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—PIK3CA—liver cancer	7.39e-05	0.000294	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—NR1H4—liver cancer	7.32e-05	0.000292	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—GSTA3—liver cancer	7.2e-05	0.000287	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—PIK3CA—liver cancer	7.08e-05	0.000282	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—GSTA4—liver cancer	6.58e-05	0.000262	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—GSTA2—liver cancer	6.41e-05	0.000256	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—AKT1—liver cancer	6.29e-05	0.000251	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—PIK3CA—liver cancer	6.23e-05	0.000248	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—GSTA1—liver cancer	6.19e-05	0.000247	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—NAT2—liver cancer	6.12e-05	0.000244	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—AKT1—liver cancer	6.03e-05	0.000241	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—ALDOB—liver cancer	5.87e-05	0.000234	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—AKT1—liver cancer	5.78e-05	0.000231	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—CRABP1—liver cancer	5.6e-05	0.000223	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—AKT1—liver cancer	5.09e-05	0.000203	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—HPGDS—liver cancer	4.89e-05	0.000195	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PSMD10—liver cancer	4.36e-05	0.000174	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PSMA4—liver cancer	4.36e-05	0.000174	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—GOT2—liver cancer	4.24e-05	0.000169	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—CYP2E1—liver cancer	3.99e-05	0.000159	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—CYCS—liver cancer	3.73e-05	0.000149	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—GOT1—liver cancer	3.66e-05	0.000146	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—GGT1—liver cancer	3.66e-05	0.000146	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—GSTP1—liver cancer	3.29e-05	0.000131	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—HMOX1—liver cancer	3.24e-05	0.000129	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—GSTM1—liver cancer	3.02e-05	0.00012	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—CYP1A1—liver cancer	2.86e-05	0.000114	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—MTHFR—liver cancer	2.67e-05	0.000106	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PPARA—liver cancer	2.62e-05	0.000104	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PIK3CG—liver cancer	2.24e-05	8.94e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PPARG—liver cancer	2.17e-05	8.63e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PIK3CD—liver cancer	1.97e-05	7.86e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—ALB—liver cancer	1.95e-05	7.76e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PIK3CB—liver cancer	1.72e-05	6.85e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PIK3CA—liver cancer	1.05e-05	4.18e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—AKT1—liver cancer	8.56e-06	3.41e-05	CbGpPWpGaD
